Dozens of pharmacists and customers are raising concerns with trade regulators about the influence of CVS Caremark Corp. over prescriptions and patient privacy. The National Community Pharmacists Association says CVS is using data on patients who don’t buy from them to attract their business. According to the Association, CVS has access to the competition’s drug prices and sensitive information such as customer identities because it controls Caremark.
CVS bought Caremark, a pharmacy benefits manager, in 2007 at a cost of more than $26 billion. CVS says the Association mischaracterizes its business and claims the Caremark deal has made pharmacy health care more “affordable and accessible.” Anybody believing that claim would be an excellent candidate to buy the London Bridge. If the American people knew the full story of how Pharmacy Benefit Managers have actually added to the cost of healthcare, they would be outraged.
Source: Associated Press
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.